Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Aptevo Therapeutics (APVO) Return on Sales (2016 - 2022)

Aptevo Therapeutics' Return on Sales history spans 8 years, with the latest figure at 0.33% for Q4 2022.

  • For Q4 2022, Return on Sales rose 24.0% year-over-year to 0.33%; the TTM value through Dec 2022 reached 0.33%, up 25.0%, while the annual FY2022 figure was 0.33%, 25.0% up from the prior year.
  • Return on Sales for Q4 2022 was 0.33% at Aptevo Therapeutics, up from 0.12% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.76% in Q2 2020 and bottomed at 6.17% in Q4 2020.
  • The 5-year median for Return on Sales is 0.05% (2021), against an average of 0.21%.
  • The largest annual shift saw Return on Sales crashed -582bps in 2020 before it surged 626bps in 2021.
  • A 5-year view of Return on Sales shows it stood at 0.01% in 2018, then tumbled by -3750bps to 0.34% in 2019, then plummeted by -1688bps to 6.17% in 2020, then skyrocketed by 101bps to 0.09% in 2021, then skyrocketed by 267bps to 0.33% in 2022.
  • Per Business Quant, the three most recent readings for APVO's Return on Sales are 0.33% (Q4 2022), 0.12% (Q3 2022), and 0.07% (Q2 2022).